gumboot, 160M is a lot, it is all invested in PBT2 for the next 16y. 10M for each year. With that patent, it could be worth 10-100 -1000 times more each year if the management will be lucky and skillful in making the deals we are expecting to happen. Stamler told that they see Big Pharma people every now and then but did not tell us that any deals were discussed with them.
That possible deal needs to be made by experts, in that field, there is nobody at present in ATH.
Presentation today, page-4
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.855K | 412.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 77143129 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 38873632 | 27 |
View Market Depth
| Last trade - 13.35pm 26/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |